Brainsway Ltd (BRSYF) 8.5000 $BRSYF
Brainsway Launches Distribution Company in the U.S.
GlobeNewswire - Tue Dec 30, 7:01AM CST
Brainsway Ltd. (TASE:BRIN) announced that in light of developments in the U.S. market, including the increased interest in Brainsway's technology and initiatives in the U.S., and in light of a heightened focus on the U.S. as Brainsway's key strategic market, the company is pleased to announce the launch of Brainsway USA INC. ("Brainsway USA"
.
Brainsway drops on CEO resignation
Seeking Alpha - at Seeking Alpha - Thu Dec 25, 6:25AM CST
Brainsway Receives IDE Approval From FDA for Launching Pivotal PTSD Multi-Center Trial
GlobeNewswire - Mon Dec 15, 7:01AM CST
Brainsway Ltd. (TASE:BRIN) announced that it received an IDE (Investigational Device Exemptions) approval from the FDA for launching a Multi-Center trial which will examine the effectiveness of Brainsway's Deep TMS (Deep Transcranial Magnetic Stimulation) for treating PTSD (Post Traumatic Stress Disorder) patients. The approval was given for 166 patients and 15 medical centers.
Brainsway Receives CE Approvals for Treating Multiple Sclerosis (MS), Stroke and Obsessive Compulsive Disorder (OCD)
GlobeNewswire - Thu Dec 04, 7:06AM CST
Brainsway Ltd. (TASE:BRIN) announced that it received a CE Marketing Approval, enabling it to immediately market and sell Brainsway Deep TMS (Deep Transcranial Magnetic Stimulation) in Europe, for treatment of Multiple Sclerosis (MS), Stroke and Obsessive Compulsive Disorder (OCD).
Brainsway Wins 2014 FLC Mid-Atlantic Regional Award for Excellence in Technology Transfer
GlobeNewswire - Mon Oct 13, 8:00AM CDT
Brainsway Ltd. (TASE:BRIN) announced that its Deep TMS treatment has won the 2014 Federal Laboratory Consortium for Technology Transfer (FLC) Mid-Atlantic Regional Award for Excellence in Technology Transfer.
Brainsway Deep TMS Brings Substantial Improvement to OCD Patients in Deep TMS Study
GlobeNewswire - Tue Sep 30, 7:39AM CDT
Brainsway Ltd. (TASE:BRIN) is pleased to report substantial improvement in OCD (Obsessive-Compulsive Disorder) patients following Brainsway Deep TMS treatment in a clinical study held in Sheba Medical center, Tel Ha'Shomer, Israel.
Brainsway Launches Distribution Company in the U.S.
GlobeNewswire - Tue Dec 30, 7:01AM CST
Brainsway Ltd. (TASE:BRIN) announced that in light of developments in the U.S. market, including the increased interest in Brainsway's technology and initiatives in the U.S., and in light of a heightened focus on the U.S. as Brainsway's key strategic market, the company is pleased to announce the launch of Brainsway USA INC. ("Brainsway USA"
. Brainsway drops on CEO resignation
Seeking Alpha - at Seeking Alpha - Thu Dec 25, 6:25AM CST
Brainsway Receives IDE Approval From FDA for Launching Pivotal PTSD Multi-Center Trial
GlobeNewswire - Mon Dec 15, 7:01AM CST
Brainsway Ltd. (TASE:BRIN) announced that it received an IDE (Investigational Device Exemptions) approval from the FDA for launching a Multi-Center trial which will examine the effectiveness of Brainsway's Deep TMS (Deep Transcranial Magnetic Stimulation) for treating PTSD (Post Traumatic Stress Disorder) patients. The approval was given for 166 patients and 15 medical centers.
Brainsway Receives CE Approvals for Treating Multiple Sclerosis (MS), Stroke and Obsessive Compulsive Disorder (OCD)
GlobeNewswire - Thu Dec 04, 7:06AM CST
Brainsway Ltd. (TASE:BRIN) announced that it received a CE Marketing Approval, enabling it to immediately market and sell Brainsway Deep TMS (Deep Transcranial Magnetic Stimulation) in Europe, for treatment of Multiple Sclerosis (MS), Stroke and Obsessive Compulsive Disorder (OCD).
Brainsway Wins 2014 FLC Mid-Atlantic Regional Award for Excellence in Technology Transfer
GlobeNewswire - Mon Oct 13, 8:00AM CDT
Brainsway Ltd. (TASE:BRIN) announced that its Deep TMS treatment has won the 2014 Federal Laboratory Consortium for Technology Transfer (FLC) Mid-Atlantic Regional Award for Excellence in Technology Transfer.
Brainsway Deep TMS Brings Substantial Improvement to OCD Patients in Deep TMS Study
GlobeNewswire - Tue Sep 30, 7:39AM CDT
Brainsway Ltd. (TASE:BRIN) is pleased to report substantial improvement in OCD (Obsessive-Compulsive Disorder) patients following Brainsway Deep TMS treatment in a clinical study held in Sheba Medical center, Tel Ha'Shomer, Israel.
